Boston Scientific: FDA 510(k) clearances across all its applicant names
FDA lists 1,355 510(k) clearances, 85 PMA and 3 De Novo decisions across the 40 applicant names Caduvo groups under Boston Scientific, first 1976, latest 2026. Median 510(k) review time across these names: 80 days. Since 2017 the median was 84 days, against 113 days for all cleared 510(k)s in the same product codes. Groups are curated by Caduvo from public sources listed below; FDA does not group applicants. Counts include filings made before an acquisition, and can include older filings by a business that was later sold when FDA records them under the same applicant name; see the notes on this page.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 40 | 92 |
| 2013 | 31 | 102 |
| 2014 | 43 | 94 |
| 2015 | 36 | 102 |
| 2016 | 24 | 70 |
| 2017 | 28 | 93 |
| 2018 | 22 | 90 |
| 2019 | 33 | 82 |
| 2020 | 23 | 74 |
| 2021 | 21 | 111 |
| 2022 | 21 | 84 |
| 2023 | 32 | 79 |
| 2024 | 19 | 85 |
| 2025 | 20 | 30 |
| 2026 | 20 | 62 |
The 40 FDA applicant names in this group
| Applicant name | 510(k) clearances | PMA | De Novo | Years |
|---|---|---|---|---|
| Boston Scientific Corp | 731 | 75 | 2 | 1988–2026 |
| Scimed Life Systems, Inc. | 109 | 2 | 0 | 1977–1998 |
| American Medical Systems, Inc. | 82 | 1 | 0 | 1979–2014 |
| Cardiac Pacemakers, Inc. | 76 | 0 | 0 | 1977–2010 |
| Meadox Medicals, Div. Boston Scientific Corp. | 53 | 1 | 0 | 1976–1997 |
| Baylis Medical Co., Inc. | 53 | 0 | 0 | 1998–2025 |
| Boston Scientific Scimed, Inc. | 35 | 5 | 0 | 1994–2004 |
| Endochoice, Inc. | 27 | 0 | 0 | 2010–2016 |
| Meadox Surgimed, Inc. | 24 | 0 | 0 | 1984–1995 |
| Schneider Intl., Ltd. | 22 | 0 | 0 | 1989–1995 |
| Microvasive | 18 | 0 | 0 | 1983–1987 |
| Ep Technologies, Inc. | 15 | 0 | 0 | 1988–2005 |
| Apollo Endosurgery, Inc. | 13 | 0 | 1 | 2008–2023 |
| Boston Scientific Neuromodulation | 10 | 1 | 0 | 2019–2025 |
| Scimed | 8 | 0 | 0 | 1990–1999 |
| Scimed Peripheral Interventions | 8 | 0 | 0 | 1993–1995 |
| Btg International, Inc. | 6 | 0 | 0 | 2014–2019 |
| Silk Road Medical, Inc. | 6 | 0 | 0 | 2013–2023 |
| Baylis Medical Technologies, Inc. | 5 | 0 | 0 | 2023–2026 |
| Boston Scientific /International Technologies | 5 | 0 | 0 | 1994–1997 |
| Boston Scientific/Medi-Tech | 5 | 0 | 0 | 2001–2002 |
| Schneider (Europe) GmbH | 5 | 0 | 0 | 1995–1999 |
| Vertiflex, Inc. | 5 | 0 | 0 | 2008–2012 |
| Bard Electrophysiology | 3 | 0 | 0 | 1989–2004 |
| Boston Scientific - Precision Vascular | 3 | 0 | 0 | 2005–2006 |
| C.R. Bard Inc., Bard Electrophysiology Division | 3 | 0 | 0 | 2008–2012 |
| Nxthera, Inc. | 3 | 0 | 0 | 2015–2018 |
| Schneider U.S. Stent Div. | 3 | 0 | 0 | 1991–1994 |
| Boston Scientific Corporation Northwest Technology | 2 | 0 | 0 | 1999–2000 |
| Boston Scientific Epi | 2 | 0 | 0 | 2003–2004 |
| Boston Scientific Ivt | 2 | 0 | 0 | 2004–2005 |
| Cogentix Medical, Inc. | 2 | 0 | 0 | 2018–2026 |
| Nxthera (A Boston Scientific Company) | 2 | 0 | 0 | 2019–2019 |
| Schneider/Namic | 2 | 0 | 0 | 1998–1999 |
| Vertiflex (Tm), Incorporated | 2 | 0 | 0 | 2007–2007 |
| Biocompatibles UK Ltd (Part of Boston Scientific Corporation | 1 | 0 | 0 | 2021–2021 |
| Boston Scientific Cardiac Diagnostic Technologies, Inc. | 1 | 0 | 0 | 2026–2026 |
| Boston Scientific EP Technologies | 1 | 0 | 0 | 2003–2003 |
| Boston Scientific Limited | 1 | 0 | 0 | 2015–2015 |
| Schneider Stent | 1 | 0 | 0 | 1989–1989 |
Review time against the same product codes
Since 2017, 510(k)s cleared under these names took a median 84 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 113 days.
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| DQX | Wire, Guide, Catheter | 97 | 97 |
| LIT | Catheter, Angioplasty, Peripheral, Transluminal | 94 | 94 |
| FGE | Stents, Drains And Dilators For The Biliary Ducts | 76 | 76 |
| DQY | Catheter, Percutaneous | 63 | 63 |
| DQO | Catheter, Intravascular, Diagnostic | 50 | 50 |
| DXY | Implantable Pacemaker Pulse-Generator | 40 | 38 |
| DRF | Catheter, Electrode Recording, Or Probe, Electrode Recording | 32 | 32 |
| DYB | Introducer, Catheter | 28 | 28 |
| GEI | Electrosurgical, Cutting & Coagulation & Accessories | 28 | 28 |
| KNS | Unit, Electrosurgical, Endoscopic (With Or Without Accessories) | 27 | 27 |
Plus 238 more product codes.
Review panels
- Cardiovascular (739)
- Gastroenterology and Urology (436)
- General and Plastic Surgery (86)
- Neurology (35)
- General Hospital (32)
- Obstetrics and Gynecology (30)
- Radiology (26)
- Anesthesiology (18)
- Orthopedic (17)
- Ear, Nose and Throat (15)
- Immunology (3)
- Clinical Chemistry (1)
- Physical Medicine (1)
- Clinical Toxicology (1)
Most recent Boston Scientific 510(k) clearances
| 510(k) | Device | Applicant name | Product code | Decision date | Review days |
|---|---|---|---|---|---|
| K262151 | SpaceOAR Flex System | Boston Scientific Corp | OVB | 2026-09-11 | 78 |
| K262460 | Rezum System | Boston Scientific Corp | KNS | 2026-09-03 | 48 |
| K261153 | LithoVue Elite Digital Flexible Ureteroscope System | Boston Scientific Corp | FGB | 2026-08-26 | 140 |
| K253692 | AVVIGO+ Multi-Modality Guidance System | Boston Scientific Corp | DQK | 2026-08-21 | 273 |
| K262406 | EluPro Antibiotic-Eluting BioEnvelope | Boston Scientific Corp | FTM | 2026-08-12 | 28 |
| K261915 | Navigator Flex Ureteral Access Sheath Set | Boston Scientific Corp | FED | 2026-08-04 | 56 |
| K262462 | TheraSphere 360 Y-90 Management Platform | Boston Scientific Corp | LLZ | 2026-07-24 | 7 |
| K262165 | FARADRIVE Steerable Sheath (M004PF21M402) | Boston Scientific Corp | DRA | 2026-07-24 | 28 |
| K261488 | OBSIDIO Conformable Embolic | Boston Scientific Corp | KRD | 2026-07-24 | 79 |
| K261978 | WallFlex Esophageal Stent System;Agile Esophageal Over-the-Wire (OTW) Stent System | Boston Scientific Corp | ESW | 2026-07-10 | 28 |
1,345 earlier clearances. See the full list in Caduvo.
PMA and De Novo decisions
| Number | Pathway | Device | Decision date |
|---|---|---|---|
| P130030 | PMA | REBEL PLATINUM CHROMIUM CORONARY STENT SYSTEM MONORAIL AND OVER THE WIRE | 2026-03-10 |
| P230035 | PMA | AGENT Paclitaxel-Coated Balloon Catheter | 2024-02-29 |
| DEN230019 | De Novo | Gallbladder Drainage Stent And Delivery System | 2023-08-18 |
| P220032 | PMA | POLARx/POLARx FIT Cryoablation Catheters, SMARTFREEZE Cryoablation Console, Accessories | 2023-08-08 |
| DEN210045 | De Novo | Endoscopic Suturing Device For Altering Gastric Anatomy For Weight Loss | 2022-07-12 |
Recalls
1,364 product recalls in 368 recall events under these names; 361 initiated in the last five years.
273 product recalls in 95 recall events filed under other recalling-firm names cite a 510(k) or PMA held under these applicant names; 49 initiated in the last five years. Most often: Boston Scientific CRM Corp (55), Boston Scientific Cork, Ltd. (41), Maquet Cardiovascular, LLC (38).
These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.
Recalling firms are matched to the applicant names above by name only, so recalls filed under other names are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Device clinical trials
ClinicalTrials.gov lists 513 device studies (70 active or recruiting) with an industry lead sponsor under the 7 sponsor names below. Most recent:
- NCT07639684: Impact of Endoscopic Sleeve Gastroplasty (ESG) in Obese Adults With Type 2 Diabetes (T2D) (Boston Scientific Corporation; Not yet recruiting, started 2027-04)
- NCT07458243: A Prospective, Multicenter, Single Arm Registry of ENROUTE NPS in Conjunction With Carotid WALLSTENT in Chinese Population (Boston Scientific Corporation; Not yet recruiting, started 2027-02-28)
- NCT07925359: The Evaluation of User Experience With FARAVIEW™ Technology of the OPAL HDx™ Mapping System When Used With the FARAWAVE NAV™ ULTRA Pulsed Field Ablation Catheter in the Treatment of Atrial Fibrillation (Boston Scientific Corporation; Not yet recruiting, started 2027-01-20)
- NCT07669727: A Post Approval Study to Evaluate Safety and Effectiveness of Multicompartmental Dosimetry Planning. (Boston Scientific Corporation; Not yet recruiting, started 2027-01)
- NCT07711093: Study of Eso-SPONGE for Treating Leaks After Upper Gastrointestinal Surgery (Boston Scientific Corporation; Not yet recruiting, started 2026-12)
| Lead sponsor name on ClinicalTrials.gov | Device studies |
|---|---|
| Boston Scientific Corporation | 487 |
| American Medical Systems | 7 |
| Apollo Endosurgery, Inc. | 6 |
| Silk Road Medical | 6 |
| Baylis Medical Company | 4 |
| VertiFlex, Incorporated | 2 |
| EndoChoice Inc. | 1 |
Sponsor names are matched to the applicant names above by name, with punctuation and legal suffixes removed, plus sponsor names reviewed for this group. Studies listed under other sponsor names are not counted.
Parent company SEC filings
BOSTON SCIENTIFIC CORP (BSX): EDGAR filings, CIK 885725. The parent's SEC registrant is entered by hand for this group, not matched by name.
How this group is built
Groups are curated by Caduvo from public sources listed below; FDA does not group applicants. Counts include filings made before an acquisition, and can include older filings by a business that was later sold when FDA records them under the same applicant name; see the notes on this page.
SciMed Life Systems (1995), Meadox (1996), Target Therapeutics (1997), Schneider (1998), Guidant's cardiac rhythm business incl. Cardiac Pacemakers Inc (2006), Bard Electrophysiology (2013), American Medical Systems urology (2015), EndoChoice (2016), BTG (2019), Baylis Medical (2022), Apollo Endosurgery (2023), Silk Road Medical (2024), Axonics (2024). Includes filings made before each acquisition. Left out: Target Therapeutics / BOSTON SCIENTIFIC TARGET (neurovascular business sold to Stryker 2011), GUIDANT (split between Abbott and Boston Scientific), AXONICS 1983–1985 (an unrelated earlier filer).
Sources
Frequently asked questions
How many FDA 510(k) clearances are listed across Boston Scientific's applicant names?
FDA lists 1,355 510(k) clearances, 85 PMA and 3 De Novo decisions across the 40 applicant names Caduvo groups under Boston Scientific, first 1976, latest 2026. FDA records each applicant name separately; Caduvo adds up the names listed on this page.
Which FDA applicant names does Boston Scientific file under?
The names with the most 510(k) clearances in this group are Boston Scientific Corp (731); Scimed Life Systems, Inc. (109); American Medical Systems, Inc. (82); Cardiac Pacemakers, Inc. (76); Meadox Medicals, Div. Boston Scientific Corp. (53). The full list of 40 names is on this page.
How long does FDA take to clear Boston Scientific 510(k)s?
The median time from FDA receipt to decision across 510(k)s cleared under these names is 80 days. Since 2017 the median was 84 days, against 113 days for all cleared 510(k)s in the same product codes.
Does the Boston Scientific count include acquired companies?
Yes. A group includes filings an acquired business made under its own name, including before the acquisition. Businesses that were sold are left out, and names whose ownership is unclear are not included. FDA does not group applicants; the sources for each grouping are listed on this page.
How many device clinical trials does Boston Scientific sponsor?
ClinicalTrials.gov lists 513 device studies (70 active or recruiting) with an industry lead sponsor under 7 sponsor names Caduvo groups under Boston Scientific. ClinicalTrials.gov names the sponsor on each study; Caduvo adds up the names listed on this page.
Next steps
- See all 1,355 Boston Scientific clearances with predicates and recalls
- Run predicate analysis for product code DQX, Boston Scientific's most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant names shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this grouping or data. Data and corrections policy.
All parent companies · FDA device companies by applicant name · FDA product code lookup